-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals only
org.
cn
PSCI should be "early prevention, early detection, early treatment", and standardized medication helps patients recover
The prevalence of stroke in China is 11,148/100,000, and many patients will be seriously affected by post-stroke cognitive impairment (PSCI) and survival time, and this part of the patient accounts for about 1/3[1].
In order to further enhance the clinical attention to PSCI and improve the corresponding diagnosis and treatment level, the Expert Consensus on the Management of Post-Stroke Cognitive Impairment [2] (hereinafter referred to as "Consensus 2021") was officially released in April 2021, which comprehensively covers the concept, diagnosis, treatment and prevention of PSCI, so as to effectively guide clinicians to standardize the management of PSCI
.
South China Railway Station - Wonderful Review
In order to help doctors at all levels quickly grasp the key contents of "Consensus 2021" and apply them to the clinic, under the guidance of the expert group of the Vascular Cognitive Disorder Branch of the Chinese Society of Stroke and the support of the "medical community" media, the "Consensus 2021" National Online Tour (South China Station) was successfully held on August 27, 2022, and Professor Zhang Junjian of Zhongnan Hospital of Wuhan University and Professor Wang Lijuan of Guangdong Provincial People's Hospital served as the chairmen of the meeting
In the first half of the conference, the "Consensus 2021" will be elaborated, Professor Ye Qinyong of the Union Hospital Affiliated to Fujian Medical University introduced that PSCI has a high incidence and low survival rate in China, and its risk prediction methods include prediction methods based on neuropsychological assessment in the acute phase of stroke and prediction methods based on PSCI risk factor models, while butylphthalide helps to improve the overall cognition of patients, and standardized prevention, management and medication will also help patients to recover clinically
.
Professor Song Luping of Shenzhen University General Hospital introduced the traditional cognitive impairment assessment and training methods of PSCI, and introduced the application
of computer-aided cognitive assessment training and VR technology in PSCI patients.
Subsequently, Professor He Dian of the Affiliated Hospital of Guizhou Medical University shared the progress of diagnosis and treatment of cerebral amyloid vascular disease, pointing out that there is no targeted disease modification treatment, and for patients with strong indications for the use of antithrombotic drugs, detailed communication is required, and the use of statins is not restricted
.
Professor Chen Ting of the Second People's Hospital of Shenzhen pointed out that PSCI needs "early prevention, early detection, early treatment", Ginkgo biloba preparations contain a variety of ingredients, can play a synergistic role, evidence-based evidence shows that it can significantly improve the neurological function and quality of life of patients after stroke, delay cognitive decline, and has good safety, has been recommended
by domestic and foreign guidelines and consensus.
In the second half of the meeting, experts discussed the clinical application of "Consensus 2021", and Professor Zhan Zengtu of the Affiliated Rehabilitation Hospital of Fujian University of Traditional Chinese Medicine and Professor Tang Chaogang of the Fifth Affiliated Hospital of Sun Yat-sen University respectively shared the rehabilitation case of a PSCI patient and a case of post-stroke aphasia in a liver transplant patient, and Professor Shi Shengliang of the Second Affiliated Hospital of Guangxi Medical University commented
on the case at the end of the conference.
The wonderful sharing of the big coffee makers in South China Station is full of aftersounds, and the next "Consensus 2021" national online lecture tour will come to the northwest region to continue to discuss the progress
of PSCI diagnosis and treatment in depth.
Northwest Station - Wonderful coming
"Consensus 2021" National Online Lecture Tour Northwest Station will be held on September 24, 2022 from 9:00-11:50 a.
m.
and will be broadcast
on the "Medical Doctor Station" platform.
The chairman of the conference will be Professor Peng Dantao of China-Japan Friendship Hospital and Meng Xinling of the Affiliated Traditional Chinese Medicine Hospital of Xinjiang Medical University
.
In the first half of the conference, "Consensus 2021" will be intensively lectured, Professor Shen Lu of Xiangya Hospital of Central South University will interpret the main points of "Consensus 2021" in detail, Professor Tian Yanghua of the Second Affiliated Hospital of Anhui Medical University will talk about the diagnosis and treatment of PSCI, and then Professor You Yong of the Second Affiliated Hospital of Hainan Medical College will also share the management of orthostatic hypotension and cerebral hypoperfusion after stroke, and Professor Gu Cheng of Gansu Provincial People's Hospital will share the application of ginkgo biloba extract in the treatment of PSCI
。
The second half of the conference will focus on the clinical application of "Consensus 2021", Professor Zhou Youting of Qinghai Provincial People's Hospital will share the efficacy of ginkgo biloba extract in the treatment of cognitive impairment of acute cerebral infarction, Professor Wang Wenhu of Ningxia Hui Autonomous Region People's Hospital will share the diagnosis and treatment of a case of Alzheimer's disease, and Professor Li Wen of the First Affiliated Hospital of the Air Force Military Medical University will conduct case evaluation
at the end of the conference.
The scene is full of dry goods, just send you to participate!
September 24, 2022 (Saturday) 9:00-11:50
Scan the QR code in the poster below
We don't see each other!
[1] MIJAJLOVIĆ M D,PAVLOVIĆ A,BRAININ M,et al.
Post-stroke dementia - a comprehensive review[J].
BMC Med,2017,15(1):11.
Vascular Cognitive Impairment Branch of Chinese Stroke Society.
Expert consensus on the management of cognitive impairment after stroke 2021[J].
Chin J Stroke, Apr 2021, Vol 16(No.
4).
org.
cn